-
Notifications
You must be signed in to change notification settings - Fork 0
/
Copy pathpubmed_data.xml
executable file
·990 lines (990 loc) · 40.8 KB
/
pubmed_data.xml
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511
512
513
514
515
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
531
532
533
534
535
536
537
538
539
540
541
542
543
544
545
546
547
548
549
550
551
552
553
554
555
556
557
558
559
560
561
562
563
564
565
566
567
568
569
570
571
572
573
574
575
576
577
578
579
580
581
582
583
584
585
586
587
588
589
590
591
592
593
594
595
596
597
598
599
600
601
602
603
604
605
606
607
608
609
610
611
612
613
614
615
616
617
618
619
620
621
622
623
624
625
626
627
628
629
630
631
632
633
634
635
636
637
638
639
640
641
642
643
644
645
646
647
648
649
650
651
652
653
654
655
656
657
658
659
660
661
662
663
664
665
666
667
668
669
670
671
672
673
674
675
676
677
678
679
680
681
682
683
684
685
686
687
688
689
690
691
692
693
694
695
696
697
698
699
700
701
702
703
704
705
706
707
708
709
710
711
712
713
714
715
716
717
718
719
720
721
722
723
724
725
726
727
728
729
730
731
732
733
734
735
736
737
738
739
740
741
742
743
744
745
746
747
748
749
750
751
752
753
754
755
756
757
758
759
760
761
762
763
764
765
766
767
768
769
770
771
772
773
774
775
776
777
778
779
780
781
782
783
784
785
786
787
788
789
790
791
792
793
794
795
796
797
798
799
800
801
802
803
804
805
806
807
808
809
810
811
812
813
814
815
816
817
818
819
820
821
822
823
824
825
826
827
828
829
830
831
832
833
834
835
836
837
838
839
840
841
842
843
844
845
846
847
848
849
850
851
852
853
854
855
856
857
858
859
860
861
862
863
864
865
866
867
868
869
870
871
872
873
874
875
876
877
878
879
880
881
882
883
884
885
886
887
888
889
890
891
892
893
894
895
896
897
898
899
900
901
902
903
904
905
906
907
908
909
910
911
912
913
914
915
916
917
918
919
920
921
922
923
924
925
926
927
928
929
930
931
932
933
934
935
936
937
938
939
940
941
942
943
944
945
946
947
948
949
950
951
952
953
954
955
956
957
958
959
960
961
962
963
964
965
966
967
968
969
970
971
972
973
974
975
976
977
978
979
980
981
982
983
984
985
986
987
988
989
990
<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet
PUBLIC '-//NLM//DTD PubMedArticle, 1st January 2019//EN'
'https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd'>
<PubmedArticleSet>
<PubmedArticle>
<MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM">
<PMID Version="1">33387232</PMID>
<DateCompleted>
<Year>2021</Year>
<Month>Sep</Month>
<Day>27</Day>
</DateCompleted>
<DateRevised>
<Year>2021</Year>
<Month>10</Month>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">1573-3432</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>51</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2023</Year>
</PubDate>
</JournalIssue>
<Title>Journal of autism and developmental disorders</Title>
<ISOAbbreviation>J Autism Dev Disord</ISOAbbreviation>
</Journal>
<ArticleTitle>A Distinct Three-Factor Structure of Restricted and Repetitive Behaviors in an Epidemiologically Sound Sample of Preschool-Age Children with Autism Spectrum Disorder.</ArticleTitle>
<VernacularTitle><sup>¿</sup>Cómo <u>hablo</u> con mi <i>familia</i> sobre <b>Gaucher</b><sub>?</sub></VernacularTitle>
<Pagination>
<MedlinePgn>3456-3468</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s10803-020-04776-x</ELocationID>
<Abstract>
<AbstractText Label="HEADER 1">Some Text for Header 1</AbstractText>
<AbstractText Label="HEADER 2">Some Text for Header 2</AbstractText>
<AbstractText Label="HEADER 3">Some Text for Header 3</AbstractText>
<CopyrightInformation>Copyright © 1993-2017, University of</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Hiruma</LastName>
<ForeName>Laura</ForeName>
<Initials>L</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0003-4192-4376</Identifier>
<AffiliationInfo>
<Affiliation>test1</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>test2</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pretzel</LastName>
<ForeName>Rebecca Edmondson</ForeName>
<Initials>RE</Initials>
<Suffix>Jr</Suffix>
<AffiliationInfo>
<Affiliation>Carolina Institute for Developmental Disabilities, University of North Carolina at Chapel Hill, Campus Box #7255, Chapel Hill, NC, 27599-7255, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tapia</LastName>
<ForeName>Amanda</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Biostatistics, Collaborative Studies Coordinating Center, University of North Carolina at Chapel Hill, Campus Box #8030, Chapel Hill, NC, 27516, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<CollectiveName>OPAL Collective</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>U10 DD000180</GrantID>
<Acronym>DD</Acronym>
<Agency>NCBDD CDC HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>CC999999</GrantID>
<Acronym>ImCDC</Acronym>
<Agency>Intramural CDC HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U10 DD000183</GrantID>
<Acronym>DD</Acronym>
<Agency>NCBDD CDC HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2021</Year>
<Month>01</Month>
<Day>02</Day>
<Hour>07</Hour>
<Minute>16</Minute>
<Second>05</Second>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Autism Dev Disord</MedlineTA>
<NlmUniqueID>7904301</NlmUniqueID>
<ISSNLinking>0162-3257</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000067877" MajorTopicYN="Y">Autism Spectrum Disorder</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001321" MajorTopicYN="Y">Autistic Disorder</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<SupplMeshList>
<SupplMeshName Type="Protocol" UI="C040721">ABDIC protocol</SupplMeshName>
<SupplMeshName Type="Protocol" UI="C034632">ABVD protocol</SupplMeshName>
<SupplMeshName Type="Protocol" UI="C034078">CVPP protocol</SupplMeshName>
<SupplMeshName Type="Protocol" UI="C014553">MOPP protocol</SupplMeshName>
</SupplMeshList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="Y">Autism spectrum disorder (ASD)</Keyword>
<Keyword MajorTopicYN="N">Exploratory factor analysis</Keyword>
<Keyword MajorTopicYN="Y">Preschool children</Keyword>
<Keyword MajorTopicYN="N">Restricted and repetitive behaviors (RRB)</Keyword>
</KeywordList>
<OtherAbstract Type="Publisher" Language="spa">
<AbstractText>Se ha estudiado el efecto de la cocción en agua sobre la capacidad antioxidante y calidad sensorial de coliflor que previamente ha sido cortada, envasada en atmósfera modificada (5,7-2,3% de CO<sub>2</sub> y 17,6-19,7% de O 2 ) y almacenada a 5 oC durante 13 días, comparándola con la coliflor recién recolectada. Se ha observado un aumento de ácido ascórbico (18%), <i>polifenoles (74%)</i> y actividad antioxidante (21%) en la coliflor almacenada cruda.</AbstractText>
</OtherAbstract>
<NumberOfReferences>38</NumberOfReferences>
<OtherID Source="NASA">00022554</OtherID>
<SpaceFlightMission>Flight Experiment</SpaceFlightMission>
<SpaceFlightMission>STS-55 Shuttle Project</SpaceFlightMission>
<SpaceFlightMission>manned</SpaceFlightMission>
<SpaceFlightMission>short duration</SpaceFlightMission>
<GeneralNote Owner="KIE">38 refs.</GeneralNote>
<ChemicalList>
<Chemical>
<RegistryNumber>QJA9M5H4IM</RegistryNumber>
<NameOfSubstance UI="D001280">Atrazine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>TE7660XO1C</RegistryNumber>
<NameOfSubstance UI="D005998">Glycine</NameOfSubstance>
</Chemical>
</ChemicalList>
<InvestigatorList>
<Investigator>
<LastName>Carlsson</LastName>
<ForeName>Christer</ForeName>
<Initials>C</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0003-4192-4376</Identifier>
<AffiliationInfo>
<Affiliation>test1</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>test2</Affiliation>
</AffiliationInfo>
</Investigator>
<Investigator>
<LastName>Cecchi</LastName>
<ForeName>Francesca</ForeName>
<Initials>F</Initials>
</Investigator>
</InvestigatorList>
<CommentsCorrectionsList>
<CommentsCorrections RefType="CommentOn">
<RefSource>J Bone Miner Res. 2015 Sep;30(9):1745</RefSource>
<PMID Version="1">26281008</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="RetractionOf">
<RefSource>Sato Y, Iwamoto J, Kanoko T, Satoh K. J Bone Miner Res. 2005 Aug;20(8):1327-33</RefSource>
<PMID Version="1">16007329</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<GeneSymbolList>
<GeneSymbol>pyrB</GeneSymbol>
<GeneSymbol>Ghox-lab</GeneSymbol>
<GeneSymbol>pulC</GeneSymbol>
</GeneSymbolList>
<PersonalNameSubjectList>
<PersonalNameSubject>
<LastName>Darwin</LastName>
<ForeName>Charles</ForeName>
<Initials>C</Initials>
</PersonalNameSubject>
<PersonalNameSubject>
<LastName>Hume</LastName>
<ForeName>David</ForeName>
<Initials>D</Initials>
</PersonalNameSubject>
<PersonalNameSubject>
<LastName>Morgan</LastName>
<ForeName>C Lloyd</ForeName>
<Initials>CL</Initials>
</PersonalNameSubject>
</PersonalNameSubjectList>
<CoiStatement>The authors declare that there is no conflict of interests regarding the publication of this paper.</CoiStatement>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="accepted">
<Year>2020</Year>
<Month>10</Month>
<Day>29</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2021</Year>
<Month>1</Month>
<Day>3</Day>
<Hour>6</Hour>
<Minute>8</Minute>
<Second>56</Second>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2021</Year>
<Month>9</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2021</Year>
<Month>1</Month>
<Day>2</Day>
<Hour>12</Hour>
<Minute>10</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">33387232</ArticleId>
<ArticleId IdType="doi">10.1007/s10803-020-04776-x</ArticleId>
<ArticleId IdType="pii">10.1007/s10803-020-04776-x</ArticleId>
<ArticleId IdType="pmc">PMC8249473</ArticleId>
<ArticleId IdType="mid">NIHMS1705367</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Neville-Towle J, Sakals S. Urinary bladder herniation through a caudoventral abdominal wall defect in a mature cat. Can. Vet. J. 2015;56:934–936.</Citation>
<ArticleIdList>
<ArticleId IdType="pmc">PMC4535508</ArticleId>
<ArticleId IdType="pubmed">26347198</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Am Acad Child Adolesc Psychiatry. 2014 Nov;53(11):1216-24</Citation>
</Reference>
<Reference>
<Citation>Eur Child Adolesc Psychiatry. 2009 Nov;18(11):675-82</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19452196</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Child Psychiatry Hum Dev. 2003 Fall;34(1):3-17</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14518620</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Autism Dev Disord. 2013 Jun;43(6):1287-97</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23065116</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Child Psychol Psychiatry. 2007 Nov;48(11):1131-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17995489</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Autism Dev Disord. 2007 Jul;37(6):1107-15</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17072748</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Autism Res. 2019 Sep;12(9):1399-1410</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31246379</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Autism Dev Disord. 2010 Jul;40(7):903-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20108116</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Child Psychol Psychiatry. 2014 Aug;55(8):945-53</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24552513</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Autism Dev Disord. 2012 Oct;42(10):2121-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22350336</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Psychol Bull. 2011 Jul;137(4):562-93</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21574682</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Autism Dev Disord. 2015 May;45(5):1271-80</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25348175</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Autism. 2004 Mar;8(1):61-87</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15070548</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Autism Dev Disord. 2014 May;44(5):1207-19</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24234675</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Autism Dev Disord. 2010 Dec;40(12):1521-30</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20405194</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Autism Dev Disord. 2012 Jan;42(1):82-93</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21384244</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Ment Retard. 2007 Jul;112(4):233-45</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17559291</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neurodev Disord. 2011 Dec;3(4):316-24</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21881965</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Ment Retard. 2006 May;111(3):199-215</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16597187</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Pediatr. 2004 Sep;145(3):391-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15343197</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Dev Psychopathol. 2010 Winter;22(1):55-69</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20102647</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Child Neuropsychol. 2006 Aug;12(4-5):247-67</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16911971</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Autism Dev Disord. 2005 Apr;35(2):145-58</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15909401</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Autism Dev Disord. 2009 May;39(5):765-74</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19148740</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Autism Dev Disord. 2007 Jan;37(1):73-85</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17195920</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Autism Res. 2013 Feb;6(1):33-41</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23258569</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Autism Res. 2013 Dec;6(6):584-95</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23868881</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Autism Dev Disord. 2007 May;37(5):855-66</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17048092</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Autism. 2008 Sep;12(5):457-72</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18805942</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Child Psychol Psychiatry. 2008 Nov;49(11):1193-200</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19017031</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Dev Neurorehabil. 2009 Jun;12(3):122-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19466619</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Autism Dev Disord. 2000 Jun;30(3):237-43</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11055459</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Autism Dev Disord. 2008 Sep;38(8):1439-50</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16900401</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Autism. 2007 Mar;11(2):161-71</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17353216</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Child Psychol Psychiatry. 2006 Jun;47(6):582-90</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16712635</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Autism Dev Disord. 2008 Sep;38(8):1518-33</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18266099</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Autism Dev Disord. 2009 Jul;39(7):1087-91</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19283461</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Autism Dev Disord. 2008 Apr;38(4):657-67</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17690967</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ObjectList>
<Object Type="Data">
<Param>This is an additional data field to store other data.</Param>
</Object>
</ObjectList>
</PubmedData>
</PubmedArticle>
<PubmedBookArticle>
<BookDocument>
<PMID Version="1">34460185</PMID>
<ArticleIdList>
<ArticleId IdType="bookaccession">NBK573263</ArticleId>
<ArticleId IdType="doi">10.17226/26295</ArticleId>
</ArticleIdList>
<Book>
<Publisher>
<PublisherName>National Academies Press (US)</PublisherName>
<PublisherLocation>Washington (DC)</PublisherLocation>
</Publisher>
<BookTitle book="nap26295">Implications for Behavioral and Social Research of Preclinical Markers of Alzheimer’s Disease and Related Dementias: Proceedings of a Workshop—in Brief</BookTitle>
<PubDate>
<Year>2021</Year>
<Month>08</Month>
<Day>24</Day>
</PubDate>
<BeginningDate>
<Year>2021</Year>
<Season>Summer</Season>
</BeginningDate>
<EndingDate>
<Year>2022</Year>
<Season>Spring</Season>
</EndingDate>
<AuthorList Type="authors">
<Author>
<CollectiveName>National Academies of Sciences, Engineering, and Medicine; Division of Behavioral and Social Sciences and Education; Board on Behavioral, Cognitive, and Sensory Sciences</CollectiveName>
</Author>
</AuthorList>
<AuthorList Type="editors">
<Author>
<LastName>Forstag</LastName>
<ForeName>Erin Hammers</ForeName>
<Initials>EH</Initials>
</Author>
</AuthorList>
<InvestigatorList>
<Investigator>
<LastName>Carlsson</LastName>
<ForeName>Christer</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator>
<LastName>Cecchi</LastName>
<ForeName>Francesca</ForeName>
<Initials>F</Initials>
</Investigator>
</InvestigatorList>
<CollectionTitle book="napcollect">The National Academies Collection: Reports funded by National Institutes of Health</CollectionTitle>
<Isbn>0309092752</Isbn>
<ELocationID EIdType="doi">10.17226/26295</ELocationID>
</Book>
<Language>eng</Language>
<PublicationType UI="D016454">Review</PublicationType>
<Abstract>
<AbstractText>On June 28-29, 2021, the National Academies of Sciences, Engineering, and Medicine held a virtual workshop, “Behavioral and Social Research and Clinical Practice Implications of Biomarkers and Other Preclinical Diagnostics of Alzheimer’s Disease (AD) and AD-Related Dementias” (AD/ADRD). The workshop was sponsored by the National Institute on Aging with the primary objective to engage in meaningful discussions about the implications of biomarkers and other preclinical diagnostics of AD and ADRD and to generate ideas for future research that might be of interest to the NIA. This publication summarizes the presentation and discussion of the workshop.</AbstractText>
<CopyrightInformation>Copyright 2021 by the National Academy of Sciences. All rights reserved.</CopyrightInformation>
</Abstract>
</BookDocument>
<PubmedBookData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>2021</Year>
<Month>8</Month>
<Day>31</Day>
<Hour>6</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2021</Year>
<Month>8</Month>
<Day>31</Day>
<Hour>6</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2021</Year>
<Month>8</Month>
<Day>31</Day>
<Hour>6</Hour>
<Minute>1</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">34460185</ArticleId>
</ArticleIdList>
</PubmedBookData>
</PubmedBookArticle>
<PubmedArticle>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">33388160</PMID>
<DateCompleted>
<Year>2021</Year>
<Month>10</Month>
<Day>12</Day>
</DateCompleted>
<DateRevised>
<Year>2021</Year>
<Month>10</Month>
<Day>12</Day>
</DateRevised>
<Article PubModel="Electronic">
<Journal>
<ISSN IssnType="Electronic">1664-8021</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>3</Volume>
<PubDate>
<Year>2012</Year>
<Month>10</Month>
<Day>12</Day>
</PubDate>
</JournalIssue>
<Title>Frontiers in genetics</Title>
<ISOAbbreviation>Front Genet</ISOAbbreviation>
</Journal>
<ArticleTitle>Genetics of melanoma.</ArticleTitle>
<Pagination>
<StartPage>330</StartPage>
<MedlinePgn>330</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">330</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.3389/fgene.2012.00330</ELocationID>
<Abstract>
<AbstractText>In 2019, the American Academy of Ophthalmology (AAO) created the Task Force on Myopia in recognition of the substantial global increases in myopia prevalence and its associated complications. The Task Force, led by Richard L. Abbott, MD, and Donald Tan, MD, comprised recognized experts in myopia prevention and treatment, public health experts from around the world, and organization representatives from the American Academy of Family Physicians, American Academy of Optometry, and American Academy of Pediatrics. The Academy's Board of Trustees believes that myopia is a high-priority cause of visual impairment, warranting a timely evaluation and synthesis of the scientific literature and formulation of an action plan to address the issue from different perspectives. This includes education of physicians and other health care providers, patients and their families, schools, and local and national public health agencies; defining health policies to ameliorate patients' access to appropriate therapy and to promote effective public health interventions; and fostering promising avenues of research.</AbstractText>
<CopyrightInformation>Copyright © 2020 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Modjtahedi</LastName>
<ForeName>Bobeck S</ForeName>
<Initials>BS</Initials>
<AffiliationInfo>
<Affiliation>Department of Ophthalmology, Southern California Kaiser Permanente, Baldwin Park, California; Department of Research and Evaluation, Southern California Permanente Medical Group, Pasadena, California.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Abbott</LastName>
<ForeName>Richard L</ForeName>
<Initials>RL</Initials>
<AffiliationInfo>
<Affiliation>Department of Ophthalmology, University of California, San Francisco, San Francisco, California.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fong</LastName>
<ForeName>Donald S</ForeName>
<Initials>DS</Initials>
<AffiliationInfo>
<Affiliation>Department of Ophthalmology, Southern California Kaiser Permanente, Baldwin Park, California; Department of Research and Evaluation, Southern California Permanente Medical Group, Pasadena, California.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lum</LastName>
<ForeName>Flora</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>American Academy of Ophthalmology, San Francisco, California. Electronic address: flum@aao.org.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tan</LastName>
<ForeName>Donald</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Eye and Retina Surgeons, Singapore, Republic of Singapore.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<CollectiveName>Task Force on Myopia</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<Language>spa</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2013</Year>
<Month>01</Month>
<Day>25</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Ophthalmology</MedlineTA>
<NlmUniqueID>7802443</NlmUniqueID>
<ISSNLinking>0161-6420</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000047" MajorTopicYN="Y">Academies and Institutes</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D026683" MajorTopicYN="Y">Advisory Committees</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006291" MajorTopicYN="Y">Health Policy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009216" MajorTopicYN="N">Myopia</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009885" MajorTopicYN="Y">Ophthalmology</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009907" MajorTopicYN="N">Optometry</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011634" MajorTopicYN="Y">Public Health</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="Y">myopia</Keyword>
<Keyword MajorTopicYN="Y">orthokeratology</Keyword>
<Keyword MajorTopicYN="Y">public health</Keyword>
<Keyword MajorTopicYN="Y">visual impairment</Keyword>
</KeywordList>
<InvestigatorList>
<Investigator ValidYN="Y">
<LastName>Ang</LastName>
<ForeName>Marcus</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Chiarito</LastName>
<ForeName>Susan</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Cotter</LastName>
<ForeName>Susan A</ForeName>
<Initials>SA</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Fernandez</LastName>
<ForeName>Angela Maria</ForeName>
<Initials>AM</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Grzybowski</LastName>
<ForeName>Andrzej</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>He</LastName>
<ForeName>Mingguang</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Jacobs</LastName>
<ForeName>Deborah S</ForeName>
<Initials>DS</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Jonas</LastName>
<ForeName>Jost B</ForeName>
<Initials>JB</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kemper</LastName>
<ForeName>Alex</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Lee</LastName>
<ForeName>Katherine A</ForeName>
<Initials>KA</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Molinari</LastName>
<ForeName>Andrea Delia</ForeName>
<Initials>AD</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Morgan</LastName>
<ForeName>Ian</ForeName>
<Initials>I</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ohno-Matsui</LastName>
<ForeName>Kyoko</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Repka</LastName>
<ForeName>Michael X</ForeName>
<Initials>MX</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Salim</LastName>
<ForeName>Sarwat</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Wu</LastName>
<ForeName>Pei-Chang</ForeName>
<Initials>PC</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Yao</LastName>
<ForeName>Ke</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Zadnik</LastName>
<ForeName>Karla</ForeName>
<Initials>K</Initials>
</Investigator>
</InvestigatorList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2020</Year>
<Month>10</Month>
<Day>19</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2020</Year>
<Month>10</Month>
<Day>27</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2020</Year>
<Month>10</Month>
<Day>29</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2021</Year>
<Month>1</Month>
<Day>4</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2021</Year>
<Month>10</Month>
<Day>13</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2021</Year>
<Month>1</Month>
<Day>3</Day>
<Hour>20</Hour>
<Minute>25</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">33388160</ArticleId>
<ArticleId IdType="pii">S0161-6420(20)31043-5</ArticleId>
<ArticleId IdType="doi">10.1016/j.ophtha.2020.10.040</ArticleId>
</ArticleIdList>
</PubmedData>
</PubmedArticle>
<PubmedBookArticle>
<BookDocument>
<PMID Version="1">34473443</PMID>
<ArticleIdList>
<ArticleId IdType="bookaccession">NBK573429</ArticleId>
<ArticleId IdType="doi">10.36255/exonpublications.amyotrophiclateralsclerosis.axonaltransport.2021</ArticleId>
</ArticleIdList>
<Book>
<Publisher>
<PublisherName>Exon Publications</PublisherName>
<PublisherLocation>Brisbane (AU)</PublisherLocation>
</Publisher>
<BookTitle book="cod9780645001778">Amyotrophic Lateral Sclerosis</BookTitle>
<PubDate>
<Year>2021</Year>
<Month>07</Month>
<Day>25</Day>
</PubDate>
<AuthorList Type="editors">
<Author>
<LastName>Araki</LastName>
<ForeName>Toshiyuki</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Department of Peripheral Nervous System Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Japan</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Edition>2nd</Edition>
<CollectionTitle book="nicepmg">NICE Process and Methods Guides</CollectionTitle>
<Isbn>9780645001778</Isbn>
<ELocationID EIdType="doi">10.36255/exonpublications.amyotrophiclateralsclerosis.2021</ELocationID>
<Medium>Internet</Medium>
<ReportNumber>Process and Methods Guides No. 12</ReportNumber>
</Book>
<LocationLabel Type="chapter">Chapter 5</LocationLabel>
<ArticleTitle book="cod9780645001778" part="Ch5">Axonal Transport and Local Translation of mRNA in Amyotrophic Lateral Sclerosis</ArticleTitle>
<Language>eng</Language>
<AuthorList Type="authors">
<Author>
<LastName>Nagano</LastName>
<ForeName>Seiichi</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurotherapeutics, Osaka University Graduate School of Medicine, Japan</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Department of Peripheral Nervous System Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Japan</Affiliation>
</AffiliationInfo>
</Author>
<Author>
<LastName>Araki</LastName>
<ForeName>Toshiyuki</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Department of Peripheral Nervous System Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Japan</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<PublicationType UI="D016454">Review</PublicationType>
<Abstract>
<AbstractText>Since neurons have long neurites, especially axons, the transport of essential mRNAs, and their translation locally in axons, are essential to maintain the shape and function of the neurons. The RNA-binding protein TDP-43 (transactive response DNA binding protein 43) plays a crucial role in the transport and translation of mRNAs in neurons. In amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD), TDP-43 and other RNA-binding proteins are mis-localized and abnormally deposited in neurons. Mutations of genes regulating these proteins have been identified in clinical cases. Impaired mRNA transport system may be a contributing factor of neurodegeneration in ALS/FTLD. In this chapter, we outline the role of RNA-binding proteins, with emphasis on TDP-43, in axonal transport and local translation of mRNAs in ALS/FTLD.</AbstractText>
<CopyrightInformation>Copyright: The Authors.</CopyrightInformation>
</Abstract>
<Sections>
<Section>
<SectionTitle book="cod9780645001778" part="Ch5" sec="Ch5-sec1">INTRODUCTION</SectionTitle>
</Section>
<Section>
<SectionTitle book="cod9780645001778" part="Ch5" sec="Ch5-sec2">FUNCTION OF RNA-BINDING PROTEINS</SectionTitle>
</Section>
<Section>
<SectionTitle book="cod9780645001778" part="Ch5" sec="Ch5-sec3">PATHOLOGICAL ROLE OF RNA GRANULES</SectionTitle>
</Section>
<Section>
<SectionTitle book="cod9780645001778" part="Ch5" sec="Ch5-sec4">RIBOSOMAL PROTEIN mRNAS AS AXONAL TRANSPORT TARGETS</SectionTitle>
</Section>
<Section>
<SectionTitle book="cod9780645001778" part="Ch5" sec="Ch5-sec5">LOCAL TRANSLATION IN AXONS IN PHYSIOLOGICAL CONDITIONS AND ALS PATHOGENESIS</SectionTitle>
</Section>
<Section>
<SectionTitle book="cod9780645001778" part="Ch5" sec="Ch5-sec6">CONCLUSION</SectionTitle>
</Section>
<Section>
<SectionTitle book="cod9780645001778" part="Ch5" sec="Ch5-references">REFERENCES</SectionTitle>
</Section>
</Sections>
<KeywordList>
<Keyword>amyotrophic lateral sclerosis</Keyword>
<Keyword>axonal transport</Keyword>
<Keyword>local translation</Keyword>
<Keyword>ribosomal protein</Keyword>
<Keyword>TDP-43</Keyword>
</KeywordList>
</BookDocument>
<PubmedBookData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>2021</Year>
<Month>9</Month>
<Day>3</Day>
<Hour>6</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2021</Year>
<Month>9</Month>
<Day>3</Day>
<Hour>6</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2021</Year>
<Month>9</Month>
<Day>3</Day>
<Hour>6</Hour>
<Minute>1</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">34473443</ArticleId>
</ArticleIdList>
</PubmedBookData>
</PubmedBookArticle>
</PubmedArticleSet>